# Lipose Corp.

- Location (FDA's records): Santa Barbara, CA
- FDA decisions: 2 (2008–2009): 2 510(k) clearances
- Product codes: QPB (1), MUU (1)
- Predicates its devices cite: 4 (0 its own); citations of its devices by later devices: 4 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cell Bio-Systems, Inc.: 2 (https://510kreport.com/company/cell-bio-systems)
- Shippert Medical Technologies Corp.: 1 (https://510kreport.com/company/shippert-medical-technologies)
- Cytori Therapeutics, Inc.: 1 (https://510kreport.com/company/cytori-therapeutics)

## Firms that cite its devices most
- Stemics S.A.S: 1 (https://510kreport.com/company/stemics)
- Biomet, Inc.: 1 (https://510kreport.com/company/biomet)
- Cytori Therapeutics, Inc.: 1 (https://510kreport.com/company/cytori-therapeutics)
- Harvest Technologies, Corp.: 1 (https://510kreport.com/company/harvest-technologies)

## Its most-cited devices
- K081848: Lipose Fat Transfer System (2008), cited by 4

## Recent decisions
- K093067: Lipose Disposable Cannula (Dec 29, 2009)
- K081848: Lipose Fat Transfer System (Dec 4, 2008)

Source page: https://510kreport.com/company/lipose